ERRT for Bipolar Disorder (BERRT Trial)

N/A

Recruiting

Led By Joanne L Davis, PhD

Research Sponsored by University of Tulsa

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Formal diagnosis of Bipolar disorder (I or II)

Nightmares at least once per week for the past month

Timeline

Screening 3 weeks

Treatment Varies

Follow Up pre, one week, three months

Awards & highlights

No Placebo-Only Group

Summary

This trial will assess whether exposure, relaxation, and rescripting therapy (ERRT) is effective in reducing nightmares and improving sleep quality in individuals diagnosed with bipolar disorder.

Who is the study for?

This trial is for adults with Bipolar Disorder (I or II) who have experienced a traumatic event over a month ago and suffer from frequent nightmares. Participants must be stable on bipolar medication for at least two months and not currently experiencing mania/hypomania, recent suicide attempts, hospitalizations, or untreated substance use disorders.

What is being tested?

The study tests ERRT-Bipolar Disorder, a therapy aimed at reducing trauma-related nightmares and improving sleep in those with bipolar disorder. The effectiveness of this psychological intervention will be evaluated by its impact on the frequency and intensity of nightmares.

What are the potential side effects?

While specific side effects are not detailed here, psychological interventions like ERRT may sometimes lead to temporary increases in distress due to confronting traumatic memories during treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with Bipolar disorder.

Select...

I have experienced nightmares at least once a week for the last month.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ pre, one week, three months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~pre, one week, three months

This trial's timeline: 3 weeks for screening, Varies for treatment, and pre, one week, three months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Past Week Nightmare Frequency

Secondary study objectives

Change in Clinician Administered PTSD Scale Symptoms

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Nightmare TreatmentExperimental Treatment1 Intervention

The nightmare treatment, Exposure, Relaxation, and Rescripting Therapy for Bipolar disorder (ERRT-Bipolar Disorder), is a weekly 5-session treatment aimed at reducing chronic trauma nightmares and sleep disturbances in adults diagnosed with bipolar disorder.

0 / 2Eligibility criteria met